View in EDS

Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis.

Saved in:
Bibliographic Details
Title: Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis.
Authors: Cardner M; Novartis Pharma AG, Basel, Switzerland.; Novartis Institutes for BioMedical Research, Basel, Switzerland., Tuckwell D; Novartis Institutes for BioMedical Research, Basel, Switzerland., Kostikova A; Novartis Institutes for BioMedical Research, Basel, Switzerland., Forrer P; Novartis Pharma AG, Basel, Switzerland., Siegel RM; Novartis Institutes for BioMedical Research, Basel, Switzerland., Marti A; Novartis Pharma AG, Basel, Switzerland., Vandemeulebroecke M; Novartis Pharma AG, Basel, Switzerland enrico.ferrero@novartis.com marc.vandemeulebroecke@novartis.com., Ferrero E; Novartis Institutes for BioMedical Research, Basel, Switzerland enrico.ferrero@novartis.com marc.vandemeulebroecke@novartis.com.
Source: RMD open [RMD Open] 2023 Jun; Vol. 9 (2).
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37321668
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cardner+M%22">Cardner M</searchLink>; Novartis Pharma AG, Basel, Switzerland.; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tuckwell+D%22">Tuckwell D</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kostikova+A%22">Kostikova A</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Forrer+P%22">Forrer P</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Siegel+RM%22">Siegel RM</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Marti+A%22">Marti A</searchLink>; Novartis Pharma AG, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Vandemeulebroecke+M%22">Vandemeulebroecke M</searchLink>; Novartis Pharma AG, Basel, Switzerland enrico.ferrero@novartis.com marc.vandemeulebroecke@novartis.com.<br /><searchLink fieldCode="AU" term="%22Ferrero+E%22">Ferrero E</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland enrico.ferrero@novartis.com marc.vandemeulebroecke@novartis.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101662038%22">RMD open</searchLink> [RMD Open] 2023 Jun; Vol. 9 (2).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group%22">BMJ Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101662038 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2056-5933 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220565933%22">20565933 </searchLink><i>NLM ISO Abbreviation: </i>RMD Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37321668
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/rmdopen-2023-003042
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cardner M
      – PersonEntity:
          Name:
            NameFull: Tuckwell D
      – PersonEntity:
          Name:
            NameFull: Kostikova A
      – PersonEntity:
          Name:
            NameFull: Forrer P
      – PersonEntity:
          Name:
            NameFull: Siegel RM
      – PersonEntity:
          Name:
            NameFull: Marti A
      – PersonEntity:
          Name:
            NameFull: Vandemeulebroecke M
      – PersonEntity:
          Name:
            NameFull: Ferrero E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2023 Jun
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2056-5933
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: RMD open
              Type: main
ResultId 1